BRIVA-LIFE - a multicentre retrospective study of the long-term use of brivaracetam in clinical practice.

V Villanueva,F J López-González,J A Mauri,J Rodriguez-Uranga,M Olivé-Gadea,J Montoya,J Ruiz-Giménez,J Zurita

Acta neurologica Scandinavica（2019）

引用 56|浏览13

暂无评分

摘要

In a large population of patients with predominantly drug-resistant epilepsy, brivaracetam was effective and well-tolerated; no unexpected AEs occurred over 1 year and the incidence of PAEs was lower compared with levetiracetam. This article is protected by copyright. All rights reserved.

查看译文

关键词

brivaracetam,clinical practice,briva-life-a,long-term

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要